Efficacy of Concerta in Treating ADHD in Mothers of Children With ADHD

• Status: Unknown status
• Trial end date: 2006-12-01
• Target enrollment: 0
• Participant gender: Female

Summary

This study involves a 7 week dose-response trial of Concerta™ methylphenidate for mothers of children with ADHD who have ADHD themselves. The aim of this study is to assess the efficacy of Concerta™ in improving adult ADHD symptoms and impairments (primary outcome), as well as observed and reported parenting (secondary outcome). The researchers hypothesize that Concerta™ will significantly decrease mothers ADHD symptoms and impairment, as well as improve observed and reported parenting

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of Maryland; University of Maryland, College Park
• Collaborators: Children's National Research Institute; Children's Research Institute; McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.
• Treatments: Methylphenidate

Criteria

Inclusion Criteria:

Mother:

• Have ADHD or problems paying attention and concentration themselves

• Have a child 6-12 years old with ADHD or possible ADHD

• Be the child's biological mother

Exclusion Criteria:

• Any CURRENT Axis I disorder (including major depression, psychosis, and substance use disorders) but with the exception of minor depressive or anxiety disorders

• Use of Anti-depressant medication

• Mothers with severe tics or Tourette's syndrome, a history of seizures or abnormal EEGs, high blood pressure, or narrowing or blockage of the GI tract

• Any women pregnant or brest-feeding